Categories: News

EPA Approves Electrostatic With Kersia/Medentech Disinfectant Tablets

WEXFORD, Ireland, Nov. 4, 2021 /PRNewswire-PRWeb/ — Kersia NaDCC effervescent disinfection tablets are the ideal disinfectant for electrostatic sprayers based on the optimal efficacy, safety, sustainability, and the ease of use with the tablets by simply filling electrostatic sprayers with tap water and dropping in a tablet (s). As an infection control leader, Kersia helps customers create a safe environment that protects employees and customers alike from exposure risks connected to SARS-CoV-2 and other pathogens such as Candida Auris, C. diff, including surface biofilms.

Kersia manufactures ranges of high-level broad spectrum NaDCC disinfectant tablets used in hospitals globally to kill harmful viral and bacterial pathogens on surfaces. Kersia products – Klorsept and Klorkleen 2, are included in the EPA N list of products that meet EPA’s criteria for use against SARS-CoV-2 and are approved by EPA as fast, effective against surface biofilm and C. diff Spores. For more information, visit http://www.NaDCCtablet.com

Media Contact

Dan Mueller, Kersia-Group, 1 206.741.5981, dan.mueller@kersia-group.com

 

SOURCE Kersia-Group

Staff

Recent Posts

Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by…

4 hours ago

AssureCare Announces Parth Shah’s Promotion to Senior Vice President of Customer Success and Enterprise AI Delivery

CINCINNATI, Feb. 3, 2026 /PRNewswire/ -- AssureCare® LLC, a leading healthcare technology company delivering an…

4 hours ago

Doxim Scales Utility Payments Team to Support Rapid Market Growth

Doxim's Utility Payments Team will drive seamless, omnichannel billing-to-payments solutions for utilities to bridge the…

4 hours ago

Amplifire Recognized by Brandon Hall Group for Breakthrough AI Authoring Technology

BOULDER, Colo., Feb. 3, 2026 /PRNewswire/ -- Amplifire, the leading adaptive learning platform built on patented…

4 hours ago

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates…

4 hours ago